medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 4

<< Back Next >>

Med Int Mex 2022; 38 (4)

Creutzfeldt-Jakob disease: a report of a case in Nuevo Leon, Mexico

Soto-Salazar LG, Favela-Aldaco S, Boland-Rodríguez E, González-Vergara LÁ, García-Villarreal F

Language: Spanish
References: 18
Page: 953-959
PDF size: 218.70 Kb.


ABSTRACT

Background: Creutzfeldt-Jakob disease is the prototype of prion illness in humans, it is a rare and clinically heterogeneous entity as well as an important differential diagnosis in rapidly progressing dementias. The definitive diagnosis is based on a biopsy of brain tissue; however, given the limitations of this study, there are diagnostic test that, in combination with the clinic, make a probable diagnosis. In Mexico there are few registered cases and there are no epidemiological data in this regard.
Clinical case: A 69-year-old male patient from Nuevo Leon, Mexico, without a significant personal history who started with a rapidly progressive dementia and myoclonic movements who presented a 14-3-3 positive protein in cerebrospinal fluid, the electroencephalogram and nuclear magnetic resonance both with typical data for Creutzfeldt-Jakob disease.
Conclusions: Creutzfeldt-Jakob disease is little suspected and in Mexico is little reported; before this situations it is important to have it in mind and include it among the differential diagnoses of neurological disease.


REFERENCES

  1. Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, GambettiP. Sporadic human prion diseases: molecular insightsand diagnosis. Lancet Neurol 2012; 11 (7): 618-28. doi:10.1016/S1474-4422(12)70063-7. Erratum in: LancetNeurol. 2012; 11 (10): 841.

  2. Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M.Creutzfeldt-Jakob disease: a systematic review of globalincidence, prevalence, infectivity, and incubation. LancetInfect Dis 2020; 20 (1): e2-e10. doi: 10.1016/S1473-

  3. 3099(19)30615-2.3. Holman RC, Belay ED, Christensen KY, Maddox RA, MininoAM, Folkema AM, Haberling DL, Hammett TA, KochanekKD, Sejvar JJ, Schonberger LB. Human prion diseases in theUnited States. PLoS One 2010; 5 (1): e8521. doi: 10.1371/journal.pone.0008521.

  4. Blumenkron D, Guerrero P, Ramiro M. Enfermedad deCreutzfeldt-Jakob. Med Int Mex 2007; 23: 34-46.

  5. Reyes MT, Aguilar S, Corona R, Vega I, Montalvo ColónC. Enfermedad de Creutzfeldt-Jakob: Reporte de un casoy revisión de la literatura. Médica Sur 2002; 9 (2):79-87.

  6. Calderón-Garcidueñas AL, Sagastegui-Rodríguez JA, Canales-Ibarra C, Farías-García R. Un caso de Creutzfeldt-Jakoben el noreste de México y revisión de conceptos actualessobre enfermedad por priones. Gac Méd Méx 2001; 137(6): 589-594.

  7. García-Ortega Y, Bravo-Ruiz O, Mireles-Ramírez M, Ramírez-Márquez J, Cabrera- Gaytán D. Enfermedad de Creutzfeldt-Jakob. Med Int Méx 2019; 35 (5): 795-801.

  8. Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology 2017;37 (2): 174-188. doi: 10.1111/neup.12355.

  9. Manix M, Kalakoti P, Henry M, Thakur J, Menger R,Guthikonda B, Nanda A. Creutzfeldt-Jakob disease: updateddiagnostic criteria, treatment algorithm, and the utilityof brain biopsy. Neurosurg Focus 2015; 39 (5): E2. doi:

  10. 10.3171/2015.8.FOCUS15328.10. Zerr I, Parchi P. Sporadic Creutzfeldt-Jakob disease. HandbClin Neurol 2018; 153: 155-174. doi: 10.1016/B978-0-444-63945-5.00009-X.

  11. Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, Lovera L,Da Prat G, Lopez- Castellanos R, Suri R, Laub H, WalkerRH, Barsottini O, Pedroso JL, Espay AJ. Movement disordersin prionopathies: A systematic review. Tremor OtherHyperkinet Mov (NY) 2019; 9. doi: 10.7916/tohm.v0.712.

  12. Geschwind MD, Murray K. Differential diagnosis with otherrapid progressive dementias in human prion diseases.Handb Clin Neurol 2018; 153: 371-397. doi: 10.1016/B978-0-444-63945-5.00020-9.

  13. CDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease(CJD), 2018. https://www.cdc.gov/prions/cjd/diagnosticcriteria.html (Accessed on June 01, 2020).

  14. Thompson AGB, Mead SH. Review: Fluid biomarkers in thehuman prion diseases. Mol Cell Neurosci 2019; 97: 81-92.doi: 10.1016/j.mcn.2018.12.003.

  15. Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 2006; 117 (5): 935-51.doi: 10.1016/j.clinph.2005.12.007.

  16. Fragoso DC, Gonçalves Filho AL, Pacheco FT, Barros BR,Aguiar Littig I, Nunes RH, Maia Júnior AC, da Rocha AJ.Imaging of Creutzfeldt-Jakob disease: Imaging patternsand their differential diagnosis. Radiographics 2017; 37(1): 234- 257. doi: 10.1148/rg.2017160075.

  17. Narula R, Tinaz S. Creutzfeldt-Jakob disease. N Engl J Med2018; 378 (4): e7. doi: 10.1056/NEJMicm1710121.

  18. Meissner B, Körtner K, Bartl M, Jastrow U, MollenhauerB, Schröter A, Finkenstaedt M, Windl O, PoserS, Kretzschmar HA, Zerr I. Sporadic Creutzfeldt-Jakobdisease: magnetic resonance imaging and clinical findings.Neurology 2004; 63 (3): 450-6. doi: 10.1212/01.wnl.0000136225.80445.c9.




2020     |     www.medigraphic.com